AnticoagEvaluator 对比 MAQI2 Anticoagulation Toolkit 的使用情况和统计数据

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator. Use the app to: • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed • Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention • Generate individualized risk for antithrombotic therapy options based on individual clinical trials. • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics. This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

AnticoagEvaluator与MAQI2 Anticoagulation Toolkit排名比较

对比 AnticoagEvaluator 与 MAQI2 Anticoagulation Toolkit 在过去 28 天内的排名趋势

排名

没有可用的数据

AnticoagEvaluator 对比 MAQI2 Anticoagulation Toolkit 的排名,按国家/地区比较

对比 AnticoagEvaluator 与 MAQI2 Anticoagulation Toolkit 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
AnticoagEvaluator VS.
MAQI2 Anticoagulation Toolkit

十二月 19, 2024